Review : Diagnosis of Helicobacter pylori infection

© 2019 John Wiley & Sons Ltd..

Endoscopic imaging of the stomach is improving. In addition to narrow band imaging, other methods, for example, blue light imaging and linked color imaging, are now available and can be combined with artificial intelligence systems to obtain information on the gastric mucosa and detect early gastric cancer. Immunohistochemistry is only recommended as an ancillary stain in case of chronic active gastritis without Helicobacter pylori detection by standard staining, and recommendations to exclude false negative H. pylori results have been made. Molecular methods using real-time PCR, droplet digital PCR, or amplification refractory mutation system PCR have shown a high accuracy, both for detecting H. pylori and for clarithromycin susceptibility testing, and can now be used in clinical practice for targeted therapy. The most reliable non-invasive test remains the 13 C-urea breath test. Large data sets show that DOB values are higher in women and that the cut-off for positivity could be decreased to 2.74 DOB. Stool antigen tests using monoclonal antibodies are widely used and may be a good alternative to UBT, particularly in countries with a high prevalence of H. pylori infection. Attempts to improve serology by looking at specific immunodominant antigens to distinguish current and past infection have been made. The interest of Gastropanel® which also tests pepsinogen levels was confirmed.

Medienart:

E-Artikel

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Zur Gesamtaufnahme - volume:24 Suppl 1

Enthalten in:

Helicobacter - 24 Suppl 1(2019) vom: 18. Sept., Seite e12641

Sprache:

Englisch

Beteiligte Personen:

Makristathis, Athanasios [VerfasserIn]
Hirschl, Alexander M [VerfasserIn]
Mégraud, Francis [VerfasserIn]
Bessède, Emilie [VerfasserIn]

Links:

Volltext

Themen:

13C urea breath test
Droplet digital PCR
Endoscopic imaging
Histology
Journal Article
Real-time PCR
Review
Serology
Stool antigen test

Anmerkungen:

Date Completed 31.12.2019

Date Revised 08.01.2020

published: Print

Citation Status MEDLINE

doi:

10.1111/hel.12641

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM300952902